Filter
4302
Filtered Results: 4302
Text search:
Africa
Centres
for
Disease
Control
and
Prevention
Center
for
Disease
Dynamics,
Economics
&
Policy
Featured
Recommendations
432
New Publications
1082
Language
Document type
No document type
2332
Studies & Reports
796
Guidelines
556
Manuals
240
Strategic & Response Plan
179
Fact sheets
62
Training Material
60
Situation Updates
35
Resource Platforms
18
Infographics
12
Brochures
9
Online Courses
2
App
1
Countries / Regions
Global
201
Sierra Leone
158
Liberia
134
Kenya
129
Nigeria
118
South Africa
115
Africa
113
Ethiopia
104
Uganda
87
Tanzania
74
Zambia
71
Malawi
70
Rwanda
65
India
65
Ghana
59
West and Central Africa
58
Western and Central Europe
57
Namibia
57
Congo, Democratic Republic of
54
Latin America and the Carribbean
52
Guinea
51
Mozambique
49
Middle East and North Africa
45
Senegal
42
East and Southern Africa
42
South Sudan
37
Lesotho
34
Syria
32
Zimbabwe
31
Burkina Faso
27
Nepal
26
Asia
26
Yemen
26
Bangladesh
25
Cameroon
20
Brazil
20
Angola
20
Botswana
20
Ukraine
19
South–East Asia Region
19
Madagascar
17
Eastern Europe
16
Russia
16
Central African Republic
16
Mali
15
Eswatini/ Swaziland
15
Haiti
13
Philippines
12
Germany
12
Pakistan
12
Colombia
11
Côte d’Ivoire / Ivory Coast
11
Benin
10
Cambodia
10
Venezuela
10
Eastern Europe and Central Asia
10
Thailand
9
Togo
9
Guinea-Bissau
9
Sudan
9
Afghanistan
8
Somalia
8
Myanmar / Burma
8
China
7
USA
7
Paraguay
7
Vietnam
7
Indonesia
7
Burundi
6
Chad
6
Gambia
5
Niger
5
Western Pacific Region
5
North America
5
Chile
4
Albania
4
Saudi Arabia
4
France
4
Portugal
4
Southern Africa
4
Lebanon
4
Papua New Guinea
4
Peru
3
Jordan
3
Bolivia
3
Sri Lanka
3
Georgia
3
Ecuador
3
Mexico
2
Turkey
2
Iran
2
Canada
2
Mauritania
2
Armenia
2
Gabon
2
Jamaica
2
Mauritius
2
Bosnia and Herzegovina
2
Argentina
2
Moldova
2
Greece
2
Libya
2
Iraq
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Malaysia
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Cape Verde
1
Turkmenistan
1
Japan
1
Belgium
1
Tunisia
1
United Kingdom
1
Spain
1
South Korea
1
Belarus
1
Israel
1
Egypt
1
Palestine
1
Authors & Publishers
Publication Years
Category
Countries
1471
Clinical Guidelines
396
Public Health
282
Key Resources
220
Women & Child Health
192
Capacity Building
65
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
HIV
410
COVID-19
389
TB
302
Ebola & Marburg
274
Mental Health
221
Rapid Response
201
NTDs
152
AMR
146
Planetary Health
132
NCDs
93
Caregiver
89
Malaria
75
Disability
74
Global Health Education
70
Refugee
67
Conflict
62
Pharmacy
54
Zika
53
Health Financing Toolbox
51
Cholera
32
Polio
29
Natural Hazards
28
Specific Hazards
13
Social Ethics
6
South Sudan
1
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
This manual is to assist health care providers and laboratory scientists to diagnose mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the clinical presentation and its diagnosis. The methods described are tailored to various levels of care and avail...
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Evaluating the Return on Investment of Scaling Up Treatment for Depression, Anxiety, and Psychosis
These guidelines promote the delivery of people-centred health services for STIs by providing evidence-based recommendations related to decentralization, integration, task sharing and digital health. These recommendations complement existing WHO guidelines for STI testing, treatment and management, ...
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
The goal of this contingency plan for El Nino related epidemics is to contribute to the reduction in mortality and morbidity associated with El Nino epidemic threats by ensuring that appropriate systems to support health emergency preparedness, timely response and post disaster recovery and mitigati...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
This interim guidance is aimed at assisting organizers of international meetings attended by individuals from EVD-affected countries and individuals with a travel history to EVD-affected countries within the previous 3 weeks.
The first part is intended for organizers of international meetings, to ...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispensable role in generating data for effective action against the AIDS pandemic. It leads the
world’s most extensive data collection on HIV epidemiology,...
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
